TD Asset Management
AH

TD Asset Management’s Accretive Health AH Stock Holding History

TD Asset Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-20,400
Closed -$187K – 1352
2013
Q4 		$187K Buy
+20,400
New +$176K ﹤0.01% 1246

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

TD Asset Management's AH Position: Q1 2014 in Review

TD Asset Management sold out of Accretive Health (AH) in Q1 2014, closing a stake of 20,400 shares — an estimated $187K sold.

TD Asset Management first reported a position in AH in Q4 2013 and held it in 1 quarter. The position peaked at $187K in Q4 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • TD Asset Management reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • TD Asset Management sold 20,400 Accretive Health shares in Q1 2014, an estimated $187K.
  • TD Asset Management first reported a position in Accretive Health in Q4 2013 and held it in 1 quarter.
  • TD Asset Management's Accretive Health position peaked at $187K in Q4 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on TD Asset Management's 13F filing for Q1 2014, filed 9 May 2014.